Nuclear Medicine AtlasInteractive atlas

Bone Scintigraphy⁹⁹ᵐTc-MDP / HDP

Whole-body, three-phase, and SPECT/CT skeletal imaging, patterns and pitfalls

Evidence B#skeletal#SPECT#bone#oncologyUpdated 2026-07-27 · Physician-reviewed
High-yield mode — key points, high-yield facts, tables & quizzes only. Toggle off for full text.

Quick Answer

Bone scintigraphy images osteoblastic activity and regional blood flow using Tc-99m-diphosphonates. Whole-body delayed imaging (~2–4 h) screens for metastases, occult fractures, and metabolic bone disease; a three-phase study (flow, blood pool, delayed) adds specificity for infection; and SPECT/CT localizes and characterizes equivocal foci as benign or malignant. It is highly sensitive but not specific — pattern recognition and correlation are everything.

Clinical Importance

Despite advances in PET and MRI, bone scintigraphy remains a workhorse for whole-body skeletal survey — inexpensive, widely available, and sensitive for osteoblastic disease (e.g. prostate, breast metastases).

Protocols

Study Phases Main use
Whole-body delayed Delayed only (2–4 h) Metastasis screening, metabolic disease
Three-phase Flow (0–60 s), blood pool (~5 min), delayed Osteomyelitis vs. cellulitis, CRPS, viability
SPECT/CT Delayed + CT Characterize equivocal foci, spine, feet

Interpretation patterns

  • Metastases: multiple randomly distributed foci, often axial; asymmetric.
  • Degenerative/traumatic: patterns following joints, ribs (linear/adjacent), consistent with mechanics.
  • Superscan: diffusely intense skeletal uptake with faint/absent kidneys and bladder ("absent kidney sign") — diffuse metastatic or metabolic bone disease.
  • Osteomyelitis: increased uptake on all three phases (vs. cellulitis, increased on flow/blood pool only).
  • Flare phenomenon: transient increased uptake in healing metastases after effective therapy — do not mistake for progression.

SPECT/CT — when it changes the read

Adding SPECT/CT to planar imaging most helps when a focus is equivocal or localization is ambiguous. High-yield uses: spine (differentiating a benign facet/endplate degenerative focus from a metastasis or pars defect), feet/wrists (small complex anatomy), solitary rib or vertebral foci, and characterizing an isolated lesion as benign versus malignant. The CT often reclassifies an indeterminate hot spot outright — degenerative, fracture, or lytic/sclerotic metastasis.

Disease-specific patterns

  • Metastatic disease: multiple asymmetric foci favoring the axial skeleton; osteoblastic tumors (prostate, breast) are especially avid.
  • Metabolic bone disease / renal osteodystrophy: superscan with increased axial and periarticular uptake, prominent calvaria/mandible, and faint kidneys.
  • Paget disease: intensely avid, expanded bone following the entire affected segment ("whole-bone" involvement).
  • Osteomyelitis vs cellulitis: three-phase study — osteomyelitis is positive on all three phases; cellulitis on flow/blood pool only.
  • Complex regional pain syndrome: classically increased periarticular uptake on delayed images.
  • Stress/insufficiency fractures: focal or linear uptake in a mechanically stressed site.

Sensitive, not specific — pattern is everything

Bone scintigraphy images osteoblastic activity and regional blood flow with Tc-99m-diphosphonates: whole-body delayed imaging screens for metastases, occult fractures, and metabolic disease; a three-phase study adds specificity for osteomyelitis (positive on all three phases vs cellulitis on flow/blood-pool only); and SPECT/CT reclassifies equivocal foci (spine, feet, solitary rib). It is highly sensitive but not specific — distribution, SPECT/CT, and priors do the work. Two traps cut against you: the post-therapy flare phenomenon (healing, not progression) and purely lytic photopenic ("cold") lesions missed on planar images.

High-Yield Pearls

  • Sensitivity is high, specificity is low — correlate distribution, use SPECT/CT, and compare priors.
  • Hydration and voiding before delayed imaging improve pelvic assessment and reduce bladder shine-through.
  • Purely lytic, aggressive lesions may be photopenic (cold) and missed on planar imaging.

Common Pitfalls

  • Flare after therapy misread as progression (repeat/interval imaging clarifies).
  • Renal/urinary contamination and injection-site extravasation mimicking lesions.
  • Solitary rib/vertebral foci over-called as metastasis — SPECT/CT and pattern resolve most.
  • Tracer: Tc-99m-MDP; pitfalls: Pearls, pitfalls & normal variants; disease: Paget disease, Osteomyelitis / diabetic foot.

Self-Check

Q1. How does a three-phase bone scan separate osteomyelitis from cellulitis?

Answer: Osteomyelitis is positive on all three phases (flow, blood pool, delayed); cellulitis is increased on flow/blood-pool only.

Q2. Describe the superscan and its "absent kidney sign."

Answer: Diffusely intense skeletal uptake with faint/absent kidneys and bladder — from diffuse metastatic or metabolic bone disease avidly taking up tracer.

Q3. After effective therapy, a known metastasis shows increased uptake. Progression or not?

Answer: Likely the flare phenomenon — transient increased uptake in healing metastases; interval imaging clarifies.

Q4. Why can an aggressive lytic lesion be missed on a planar bone scan?

Answer: It may be photopenic (cold) — little osteoblastic response — so it is easy to overlook without SPECT/CT or correlation.

Evidence & sources

BSNMMI procedure standard / EANM guideline for bone scintigraphy — three-phase technique, SPECT/CT, and interpretation.
Cite this page. Nuclear Medicine Atlas. “Bone Scintigraphy.” v1.76, 2026-10-25. Permalink: https://nuc.med/bone-scintigraphy/ Report an issue
Nuclear Medicine Atlas · v1.76 · built 2026-10-25Terms · Privacy · Disclaimer